Cargando…

AB001. Understanding transcriptional connections of chronic cutaneous lupus erythematosus between humans and animal models

Chronic cutaneous lupus erythematosus (CCLE) exhibits severe inflammatory processes that lead to decreased quality of life (QoL) and potential skin scarring with disfiguration; treatment of CCLE has a high unmet need for effective and safe therapeutics. To determine biological pathways and transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banovic, Frane, Blubaugh, Amanda, Denley, Tara, Gogal, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Abstract on Rheumatologic Skin Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033392/ http://dx.doi.org/10.21037/atm.2021.AB001

Ejemplares similares

AB006. A modular analysis approach to studying gene expression in cutaneous lupus erythematosus
por: Zhu, Jane, et al.
Publicado: (2021)

AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021)

AB004. Evaluating differences in meaningful change in disease activity between different races and clinical subtypes affected by cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021)

AB003. Increased CD69+ tissue-resident memory T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials
por: Zeidi, Majid, et al.
Publicado: (2021)

AB024. A case of bullous systemic lupus erythematosus confined to the oral mucosa
por: Strunck, Jennifer, et al.
Publicado: (2021)

AB023. An atypical clinical presentation of alopecia in two patients with systemic lupus erythematosus
por: Lerman, Irina, et al.
Publicado: (2021)

AB002. Quality of life is inversely related to income in patients with cutaneous lupus
por: Prasad, Smriti, et al.
Publicado: (2021)

AB009. Successful treatment of severe systemic lupus erythematosus and psoriasis with IL-17A inhibition
por: Robinett, Danielle M., et al.
Publicado: (2021)

AB007. Worse skin disease severity may distinguish patients who progress from cutaneous lupus erythematous to systemic lupus erythematous
por: Walocko, Frances, et al.
Publicado: (2021)

Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus
por: Zhu, Jane L., et al.
Publicado: (2021)

AB020. A case report on cutaneous necrotizing vasculitis treated with colchicine in a Filipino adult male
por: Cruz, Luisa Marie S., et al.
Publicado: (2021)

AB010. Keloidal scleroderma with isolated intertriginous involvement
por: Balakrishnan, Vijay, et al.
Publicado: (2021)

AB022. Biologics and vaccination: relationship of influenza, pneumonia and zoster
por: Patel, Deep, et al.
Publicado: (2021)

AB025. Acute arthritis with dermatitis: a case of multicentric reticulohistiocytosis
por: Niaki, Omid Zahedi, et al.
Publicado: (2021)

The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review
por: Chakka, Srita, et al.
Publicado: (2021)

AB015. Skin disease activity and autoantibody phenotype are major determinants of blood interferon signatures in dermatomyositis
por: Tabata, Mika, et al.
Publicado: (2021)

AB011. A Gottron’s papule mimicker: an unusual presentation of porokeratosis plantaris palmaris et disseminata
por: Schoenberg, Elizabeth, et al.
Publicado: (2021)

AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
por: Concha, Josef Symon S., et al.
Publicado: (2021)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

AB008. Utility of repeat latent tuberculosis testing in patients with immune-mediated diseases taking biologics
por: Khanna, Urmi, et al.
Publicado: (2021)

AB021. Comparing the performance of two interferon-gamma release assays in autoimmune skin disease patients: a prospective study
por: Krain, Rebecca L., et al.
Publicado: (2021)

AB017. Increased dendritic cells and IFN-beta and MxA protein expression in spongiotic dermatitis differentiates dermatomyositis from eczema
por: Zeidi, Majid, et al.
Publicado: (2021)

AB013. CXCL4-DNA immune complexes drive inflammation in systemic sclerosis by amplifying TLR9-mediated interferon-α production
por: Lee, Ernest Y., et al.
Publicado: (2021)

AB018. Myeloid dendritic cells (mDCs) are major producers of interferon-beta in dermatomyositis and increased numbers of mDCs are found in hydroxychloroquine nonresponders
por: Chen, Kristen L., et al.
Publicado: (2021)

AB012. Clinical and demographic features of morphea patients with mucocutaneous involvement: a cross sectional study from the morphea of adults and children (MAC cohort)
por: Prasad, Smriti, et al.
Publicado: (2021)

AB016. A double-blind, placebo-controlled, phase 2 trial of a novel toll-like receptor 7/8/9 antagonist (IMO-8400) in dermatomyositis
por: Kim, Yoo Jung, et al.
Publicado: (2021)

Cutaneous lupus erythematosus in dogs: a comprehensive review
por: Olivry, Thierry, et al.
Publicado: (2018)

Advances in cutaneous vasculitis research and clinical care
por: Caplan, Avrom, et al.
Publicado: (2021)

Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis
por: Castillo, Rochelle L., et al.
Publicado: (2021)

Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020)

Discoid Lupus Erythematosus-Associated Cutaneous Squamous Cell Carcinoma in Systemic Lupus Erythematosus
por: Alkan Melikoglu, Meltem, et al.
Publicado: (2022)

Pruritus in autoimmune connective tissue diseases
por: Kim, Hee Joo
Publicado: (2021)

Human cutaneous B cells: what do we really know?
por: Lerman, Irina, et al.
Publicado: (2021)

Evans Syndrome in the Context of Incomplete Systemic Lupus Erythematosus
por: Abu Kar, Sarah, et al.
Publicado: (2022)

Assessment of Mean Platelet Volume in Patients with Systemic Lupus Erythematosus
por: Hartmann, Lisandra Torres, et al.
Publicado: (2018)

Chylous Ascites in Systemic Lupus Erythematosus: A Diagnostic Challenge
por: Hasan, Badar, et al.
Publicado: (2017)

A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2022)

A Practical Overview of the Articular Manifestations of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2023)

Case definitions in Swedish register data to identify systemic lupus erythematosus
por: Arkema, Elizabeth V, et al.
Publicado: (2016)

Peripheral Gangrene as the Initial Presentation of Systemic Lupus Erythematosus in Emergency Department
por: Alalawi, Zainab M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rthtjua92jlfbbk6ejbvi994j6